Neogen Corporation
NASDAQ:NEOGMedical - Diagnostics & Research
+$0.16 today
- Market cap
- $2.42B
- Beta
- 1.80
- P/E (TTM)
- -3.3
- EPS (TTM)
- -$2.80
Volume 1.79M
Average 2.53M
NEOG Change in Working Capital
Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.
Neogen CorporationNASDAQ: NEOG
Change in Working Capital · Q1 FY2027 · quarter ended Aug 2026
Change in working capital turns negative
Q1 FY2027 change in working capital was -$5.1M, compared with $21.47M a year earlier. Trailing-twelve-month change in working capital was $32.23M.
Context
- Change in working capital amounted to 6.8% of revenue in FY2026, up 6.1 pp from a year earlier.
- Change in working capital increased in 2 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly change in working capital holds near -$5.1M or moves back toward the trailing-twelve-month quarterly average of $8.06M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Change in Working Capital history
USD · from the cash flow
- Latest · FY2026
- 58.8M USD
- Year-over-year change
- +1091.2%
| Period | Period end | Change in Working Capital | YoY change |
|---|---|---|---|
| FY2026 | 2026-05-31 | 58.8M | +1091.2% |
| FY2025 | 2025-05-31 | (5.93M) | +91.8% |
| FY2024 | 2024-05-31 | (72.68M) | -200.4% |
| FY2023 | 2023-05-31 | (24.2M) | -447.3% |
| FY2022 | 2022-05-31 | (4.42M) | — |
Change in Working Capital vs competitors
How NEOG compares with its peers on the latest reported figures
- NEOG's LTM Aug 2026 change in working capital of $32.23M is the 5th largest of the 7 companies compared; the peer median is $35.56M.
- Its year-over-year change of -30.2% is the 4th highest of 7, against a peer median of +37.0%.
- Change in working capital amounts to 3.6% of revenue for NEOG, versus a peer median of 1.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.25B | -76.1% | +35.9% | 1.9% | |
| LTM Sep 2026 | $225M | +150.2% | — | 4.4% | |
| LTM Mar 2026 | $99.59M | -833.0% | -21.5% | 6.6% | |
| LTM Sep 2026 | $52.12M | +496.7% | -6.0% | 1.1% | |
| LTM Aug 2026 | $32.23M | -30.2% | — | 3.6% | |
| LTM Jun 2026 | $19M | -151.4% | -16.4% | 0.2% | |
| LTM Sep 2026 | $9.32M | +772.5% | -33.4% | 0.8% | |
| Peer median (excluding NEOG) | $35.56M | +37.0% | -16.4% | 1.5% | |
Competitors are the stored peer set for NEOG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 May 2022 | FY2023 May 2023 | FY2024 May 2024 | FY2025 May 2025 | FY2026 May 2026 |
|---|---|---|---|---|---|
| Net Income | 48.31M | (22.87M) | (9.42M) | (1.09B) | (7.9M) |
| Depreciation & Amortization | 24.13M | 90.47M | 121.23M | 125.67M | 116.3M |
| Deferred Income Tax | (4.7M) | (19.23M) | (27.42M) | (57.78M) | (24.3M) |
| Stock-Based Compensation | 7.15M | 10.18M | 13.77M | 17.29M | 13.4M |
| Change in Working Capital | (4.42M) | (24.2M) | (72.68M) | (5.93M) | 58.8M |
| Accounts Receivables | (7.8M) | (53.88M) | (20.1M) | 11.64M | 6.8M |
| Inventory | (21.07M) | 9.96M | (55.95M) | (16.12M) | 38.2M |
| Accounts Payables | 20.24M | 18.64M | 13.75M | (402K) | 19.8M |
| Other Working Capital | 4.21M | 1.09M | (10.38M) | (1.05M) | (6M) |
| Other Non-Cash Items | (2.44M) | 6.67M | 9.8M | 1.07B | (73.1M) |
| Operating Cash Flow | 68.04M | 41.03M | 35.26M | 58.24M | 83.2M |
| Capital Expenditures | (24.43M) | (65.76M) | (111.42M) | (104.6M) | (51.3M) |
| Acquisitions (Net) | (38.75M) | 12.55M | 108K | 5.08M | 121.7M |
| Purchases of Investments | (415.89M) | (12.52M) | 0 | 0 | 0 |
| Sales of Investments | 381.84M | 266.77M | 82M | 325K | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 100K |
| Investing Cash Flow | (97.23M) | 201.04M | (29.31M) | (99.2M) | 70.5M |
| Debt Repayment | 0 | (100M) | (420K) | (321K) | (100M) |
| Common Stock Issued | 7.93M | 1.2M | 2.46M | 2.24M | 1.6M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (1.12M) | (19.28M) | (118K) | (3.52M) | (1M) |
| Financing Cash Flow | 6.81M | (118.08M) | 1.92M | (1.6M) | (99.4M) |
| Effect of Forex Changes | (8.75M) | (5.22M) | (502K) | 942K | 2.2M |
| Net Change in Cash | (31.13M) | 118.77M | 7.37M | (41.61M) | 56.5M |
| Free Cash Flow | 43.61M | (24.73M) | (76.16M) | (46.35M) | 31.9M |
Neogen Corporation
NASDAQ:NEOG
Intrinsic Alpha fair value
Locked
Current Price
$11.08
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.